David Schaaf
Direttore Tecnico/Scientifico/R&S presso PDS BIOTECHNOLOGY CORPORATION
Posizioni attive di David Schaaf
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| PDS BIOTECHNOLOGY CORPORATION | Direttore Tecnico/Scientifico/R&S | 01/09/2022 | - |
Storia della carriera di David Schaaf
Precedenti posizioni note di David Schaaf
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ZOGENIX, INC. | Direttore Tecnico/Scientifico/R&S | - | - |
Formazione di David Schaaf
| The Trustees of Columbia University in The City of New York | Graduate Degree |
| Stanford University | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
Posizioni
| Chief Tech/Sci/R&D Officer | 2 |
| Graduate Degree | 1 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| PDS BIOTECHNOLOGY CORPORATION | Health Technology |
| Aziende private | 1 |
|---|---|
Zogenix, Inc.
 Zogenix, Inc. Pharmaceuticals: MajorHealth Technology Zogenix, Inc. is a pharmaceutical company. The firm engages in the development and commercialization of central nervous system (CNS) therapies and products for the treatment orphan diseases and other CNS disorders. Its products include Fintepla and MT1621. The company was founded by Stephen James Farr, Cam L. Garner, Roger L. Hawley, Bret E. Megargel, Jonathan M. N. Rigby, Scott L. Glenn, and John J. Turanin on May 11, 2006 and is headquartered in Emeryville, CA. | Health Technology |
- Borsa valori
- Insiders
- David Schaaf
- Esperienza
